Doseology Sciences Inc. (CSE:MOOD)

Market Cap	528.06K
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	4.40M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	3,217
Open	0.120
Previous Close	0.170
Day's Range	0.120 - 0.120
52-Week Range	0.070 - 0.550
Beta	-3.12
RSI	33.96
Earnings Date	n/a

About Doseology Sciences

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of nutraceutical products in Canada. The company offers medicinal mushroom products, including tinctures, powders, and herbal supplements to enhance health with a focus on mental health. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in Januar...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MOOD